{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:21:30Z","timestamp":1768029690465,"version":"3.49.0"},"reference-count":50,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Clinical Research Committee of Japan Society of Hematopoietic Cell Transplantation","award":["7124055716"],"award-info":[{"award-number":["7124055716"]}]},{"DOI":"10.13039\/501100014807","name":"Nagoya University Hospital","doi-asserted-by":"crossref","award":["Funding for Clinical Development (71004228)"],"award-info":[{"award-number":["Funding for Clinical Development (71004228)"]}],"id":[{"id":"10.13039\/501100014807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Practical Research Project for Allergic Diseases and Immunology","award":["19ek0510020s0103"],"award-info":[{"award-number":["19ek0510020s0103"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,10,28]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>A better long-term quality of life after umbilical cord blood transplantation (CBT) is observed compared with transplants from other alternative donors, whereas graft failure and relapses after CBT are still major issues. To minimise graft failure and relapse after CBT, intensification of conditioning by the addition of high-dose cytosine arabinoside (CA) and concomitant continuous use of granulocyte-colony stimulating factor (G-CSF) are reported to convey a significantly better survival after CBT in some retrospective studies. To confirm the effect of G-CSF plus CA combination, in addition to the standard conditioning regimen, cyclophosphamide (CY)\/total body irradiation (TBI), we design a randomised controlled study comparing CA\/CY\/TBI with versus without G-CSF priming (G-CSF combined conditioned cord blood transplantation [G-CONCORD] study).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a multicentre, open-label, randomised phase III study that aimed to compare G-CSF+CA\/CY\/TBI as a conditioning regimen for CBT with CA\/CY\/TBI. Patients with acute myeloid leukaemia or myelodysplastic syndrome, aged 16\u201355 years, are eligible. The target sample size is 160 and the registration period is 4 years. The primary endpoint is the 2-year disease-free survival rate after CBT. The secondary endpoints are overall survival, relapse, non-relapse mortality, acute and chronic graft-versus-host disease, engraftment rate, time to neutrophil recovery, short-term adverse events, incidence of infections and causes of death.<\/jats:p>\n                    <jats:p>This study employs a single one-to-one web-based randomisation between the with-G-CSF versus without-G-CSF groups after patient registration. Combination of high-dose CA and CY\/TBI in both groups is used for conditioning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol was approved by the central review board, Nagoya University Certified Review Board, after the enforcement of the Clinical Trials Act in Japan. The manuscripts presenting data from this study will be submitted for publication in quality peer-reviewed medical journals. Study findings will be disseminated via presentations at national\/international conferences and peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>UMIN000029947 and jRCTs041180059.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-040467","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T18:03:59Z","timestamp":1607105039000},"page":"e040467","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine\/cyclophosphamide\/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-8046","authenticated-orcid":false,"given":"Seitaro","family":"Terakura","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Konuma","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, The Institute of Medical Science The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyasu","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Tokai University School of Medicine Graduate School of Medicine, Isehara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nanno","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaka City University Graduate School of Medicine School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Aotsuka","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Japanese Red Cross Society Narita Hospital, Narita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organisation Kumamoto Medical Center, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kato","sequence":"additional","affiliation":[{"name":"Division of Hematology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medicine, Tohoku University, Sendai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yachiyo","family":"Kuwatsuka","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, The Institute of Medical Science The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"2025121221461847000_10.12.e040467.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-604546"},{"key":"2025121221461847000_10.12.e040467.2","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for blood and marrow transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol"},{"key":"2025121221461847000_10.12.e040467.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-453175"},{"key":"2025121221461847000_10.12.e040467.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203517"},{"key":"2025121221461847000_10.12.e040467.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001212"},{"key":"2025121221461847000_10.12.e040467.6","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.2019001323","article-title":"How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide","volume":"134","author":"McCurdy","year":"2019","journal-title":"Blood"},{"key":"2025121221461847000_10.12.e040467.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041276"},{"key":"2025121221461847000_10.12.e040467.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041469"},{"key":"2025121221461847000_10.12.e040467.9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41409-020-0859-8","article-title":"Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome","volume":"55","author":"Terakura","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"2025121221461847000_10.12.e040467.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-354563"},{"key":"2025121221461847000_10.12.e040467.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602074"},{"key":"2025121221461847000_10.12.e040467.12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12185-019-02672-4","article-title":"Single cord blood transplantation in Japan; expanding the possibilities of CBT","volume":"110","author":"Yamamoto","year":"2019","journal-title":"Int J Hematol"},{"key":"2025121221461847000_10.12.e040467.13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018028662"},{"key":"2025121221461847000_10.12.e040467.14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.149427"},{"key":"2025121221461847000_10.12.e040467.15","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030171"},{"key":"2025121221461847000_10.12.e040467.16","article-title":"Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017","author":"Konuma","year":"2019","journal-title":"Am J Hematol"},{"key":"2025121221461847000_10.12.e040467.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-642652"},{"key":"2025121221461847000_10.12.e040467.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-020172"},{"key":"2025121221461847000_10.12.e040467.19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.114504"},{"key":"2025121221461847000_10.12.e040467.20","first-page":"826","article-title":"Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro","volume":"4","author":"Tafuri","year":"1990","journal-title":"Leukemia"},{"key":"2025121221461847000_10.12.e040467.21","first-page":"2076","article-title":"Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells","volume":"8","author":"Tosi","year":"1994","journal-title":"Leukemia"},{"key":"2025121221461847000_10.12.e040467.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.05.009"},{"key":"2025121221461847000_10.12.e040467.23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/bmt.2016.255","article-title":"Exploratory research for optimal GVHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GVHD more than mycophenolate mofetil","volume":"52","author":"Terakura","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"2025121221461847000_10.12.e040467.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"2025121221461847000_10.12.e040467.25","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2025121221461847000_10.12.e040467.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.5696"},{"key":"2025121221461847000_10.12.e040467.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-552984"},{"key":"2025121221461847000_10.12.e040467.28","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1200\/JCO.1991.9.11.2016","article-title":"Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation","volume":"9","author":"Shepherd","year":"1991","journal-title":"J Clin Oncol"},{"key":"2025121221461847000_10.12.e040467.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1001"},{"key":"2025121221461847000_10.12.e040467.30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/bmt.2016.255","article-title":"Exploratory research for optimal GVHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GVHD more than mycophenolate mofetil","volume":"52","author":"Terakura","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"2025121221461847000_10.12.e040467.31","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"2025121221461847000_10.12.e040467.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.01.001"},{"key":"2025121221461847000_10.12.e040467.33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704512"},{"key":"2025121221461847000_10.12.e040467.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"key":"2025121221461847000_10.12.e040467.35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cct.2015.12.007","article-title":"Methods for flexible sample-size design in clinical trials: likelihood, weighted, dual test, and promising zone approaches","volume":"47","author":"Shih","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"2025121221461847000_10.12.e040467.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2025121221461847000_10.12.e040467.37","doi-asserted-by":"publisher","DOI":"10.2307\/2670170"},{"key":"2025121221461847000_10.12.e040467.38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bjh.14652","article-title":"Increased non-relapse mortality due to high-dose cytarabine plus CY\/TBI in BMT\/PBSCT for acute lymphoblastic leukaemia in adults","volume":"178","author":"Arai","year":"2017","journal-title":"Br J Haematol"},{"key":"2025121221461847000_10.12.e040467.39","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.236"},{"key":"2025121221461847000_10.12.e040467.40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.1996.14.1.220","article-title":"Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors","volume":"14","author":"Anderson","year":"1996","journal-title":"J Clin Oncol"},{"key":"2025121221461847000_10.12.e040467.41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajh.24933","article-title":"Improved prognosis with additional medium-dose VP16 to CY\/TBI in allogeneic transplantation for high risk ALL in adults","volume":"93","author":"Arai","year":"2018","journal-title":"Am J Hematol"},{"key":"2025121221461847000_10.12.e040467.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.05.003"},{"key":"2025121221461847000_10.12.e040467.43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-258442"},{"key":"2025121221461847000_10.12.e040467.44","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/s41409-020-0853-1","article-title":"Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation","volume":"55","author":"Kanda","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"2025121221461847000_10.12.e040467.45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/leu.2016.288","article-title":"Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation","volume":"31","author":"Kanda","year":"2017","journal-title":"Leukemia"},{"key":"2025121221461847000_10.12.e040467.46","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/bmt.2017.116","article-title":"GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia","volume":"52","author":"Terakura","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"2025121221461847000_10.12.e040467.47","first-page":"239","article-title":"Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia","volume":"13","author":"Takahashi","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"2025121221461847000_10.12.e040467.48","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1607"},{"key":"2025121221461847000_10.12.e040467.49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-389841"},{"key":"2025121221461847000_10.12.e040467.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025406"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-040467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:46:27Z","timestamp":1765604787000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-040467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,4]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/bmjopen-2020-040467"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-040467","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}